Significance and implications of capillaritis during acute rejection of kidney allografts

Transplantation. 2010 May 15;89(9):1088-94. doi: 10.1097/TP.0b013e3181d368f1.

Abstract

BACKGROUND.: Anti-human leukocyte antigen antibodies (a-HLA) cause graft injury identified by C4d in peritubular capillaries. We investigated whether a-HLA relate to episodes of C4d negative acute rejection (AR). METHODS.: We analyzed 878 kidney recipients transplanted from January 2000 to December 2006. Pretransplant, 36% of these crossmatch negative recipients had a-HLA measured by solid phase assays. RESULTS.: AR occurred in 154 patients (18%) and 11 of them (9.4%) were C4d+. Forty-six percent of ARs were diagnosed by protocol biopsy. The risk of C4d-AR was increased in patients with a-HLA class I with donor specificity (DSA-I) (hazard ratio=1.519; confidence interval, 1.02-2.26; P=0.039). DSA-II were not associated with an increased risk of C4d-AR. The relationship between DSA-I and C4d-AR was independent of recipient age, BK nephropathy, and HLA mismatches. Compared with DSA-, in DSA+ recipients C4d-AR were most often histologically "borderline." DSA+ was associated with capillaritis in the biopsy (glomerulitis, 6.1% vs. 32%, P=0.003; peritubular capillaritis: 13% vs. 40%, P=0.0009). Compared with no AR, C4d-AR with capillaritis was associated with reduced graft survival (hazard ratio=4.164; confidence interval, 1.763-9.832; P=0.001), independent of other variables. This association was observed even in the cases of borderline AR. CONCLUSIONS.: DSA-I increases the risk of C4d-AR. The presence of DSA-I or II is associated with capillaritis during AR. Capillaritis is associated with reduced graft survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Autoantibodies / blood
  • Cadaver
  • Capillaries / immunology
  • Capillaries / pathology*
  • Complement C4b / analysis*
  • Female
  • Graft Rejection / immunology*
  • Graft Rejection / pathology
  • HLA Antigens / immunology
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / immunology
  • Kidney Transplantation / mortality
  • Kidney Transplantation / pathology
  • Living Donors
  • Male
  • Peptide Fragments / analysis*
  • Survivors
  • Tissue Donors
  • Transplantation, Homologous / immunology
  • Transplantation, Homologous / pathology

Substances

  • Autoantibodies
  • HLA Antigens
  • Peptide Fragments
  • Complement C4b
  • complement C4d